SEC Form 4 · accession 0001567619-19-001303
Medpace Holdings, Inc. · MEDP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Medpace Investors, LLC
10% Owner
Period of report
Jan 15, 2019
Accepted (ET)
Jan 17, 2019 · 4:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001668397
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 15, 2019 | S | 600 | $61.00 | D | 8,150,525 | D | |
| Common StockF1,F3 | Jan 16, 2019 | S | 7,222 | $61.57 | D | 8,143,303 | D | |
| Common StockF1,F4 | Jan 17, 2019 | S | 8,760 | $61.17 | D | 8,134,543 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018.
- F2The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $61.00 to $61.01. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
- F3The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $61.00 to $62.07. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
- F4The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $61.00 to $61.34. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.